| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/18/2009 | US20090156606 Optical correction |
| 06/18/2009 | US20090156605 Quinolones and azaquinolones that inhbit prolyl hydroxylase |
| 06/18/2009 | US20090156604 Fused bicyclic imidazoles |
| 06/18/2009 | US20090156603 2-aminopyridine analogs as glucokinase activators |
| 06/18/2009 | US20090156602 Organic Compounds |
| 06/18/2009 | US20090156601 kinase inhibitor; immunotherapy; viricides; function or behavior associated with PI3 kinase such as cancer, immune, cardiovascular, nervous system, metabolism/endocrine and neurological diseases, viral infection, inflammation; 2-(3-hydroxyphenyl)-4-(morpholin-4-yl)-6-(pyridin-3-ylmethylamino) pyrimidine |
| 06/18/2009 | US20090156600 Quinolines and Their Therapeutic Use |
| 06/18/2009 | US20090156599 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of TRPV1 |
| 06/18/2009 | US20090156598 Imidazolopyrimidine modulators of TRPV1 |
| 06/18/2009 | US20090156597 Novel Compounds |
| 06/18/2009 | US20090156596 Unsaturated Heterocyclic Derivatives |
| 06/18/2009 | US20090156595 Pteridines useful as HCV inhibitors and methods for the preparation thereof |
| 06/18/2009 | US20090156594 Heterocyclic kinase modulators |
| 06/18/2009 | US20090156593 Spirocyclic Azaindole Derivatives |
| 06/18/2009 | US20090156591 Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors |
| 06/18/2009 | US20090156590 Vanilloid Receptor Ligands, Pharmaceutical Compositions Containing Them, Process for Making Them, and Use Thereof for Treating Pain and Other Conditions |
| 06/18/2009 | US20090156589 1,2-di(cyclic group)substituted benzene derivative |
| 06/18/2009 | US20090156588 such as 3-[4-(tert-Butyl-dimethyl-silanyloxy)-phenyl]-7-hydroxy-3,4-dihydro-benzo[e][1,3]oxazin-2-one, inhibitors macrophage migration inhibitory factor isomerase activity; treatment of vision defects, ischemia, inflammatory, autoimmune, bone, nervous system, cardiovascular and gastrointestinal disorders |
| 06/18/2009 | US20090156587 Eye Medication Formulation with Antibacterial Agent |
| 06/18/2009 | US20090156586 Compounds for the treatment of inflammatory disorders |
| 06/18/2009 | US20090156585 Organic compounds |
| 06/18/2009 | US20090156584 Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam |
| 06/18/2009 | US20090156583 Tricyclic Amide Derivatives |
| 06/18/2009 | US20090156582 Pyrazole Compound |
| 06/18/2009 | US20090156581 Aminergic pharmaceutical compositions and methods |
| 06/18/2009 | US20090156580 Anti-foot-and-mouth disease virus agent for animal belonging to family suidae or sheep, and method for prevention or treatment of foot-and-mouth disease in animal belonging to family suidae or sheep |
| 06/18/2009 | US20090156579 Combination of a Dipeptidyl Peptidase-4 Inhibitor and an Anti-Hypertensive Agent for the Treatment of Diabetes and Hypertension |
| 06/18/2009 | US20090156578 3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents |
| 06/18/2009 | US20090156577 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones |
| 06/18/2009 | US20090156576 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases |
| 06/18/2009 | US20090156575 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 06/18/2009 | US20090156574 N-(4-(5-Butyl-2-methoxyphenyl)-1,3-thiazol-2-yl)-4-((4-oxopiperidin-1-yl)carbonyl)benzamide; antiinflammatory, anticarcinogenic, antidiabetic, analgesic agents |
| 06/18/2009 | US20090156573 N-(Aminoheteroaryl)-1H-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 06/18/2009 | US20090156572 Nitrogen-containing heterocyclic compound and use thereof |
| 06/18/2009 | US20090156571 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/18/2009 | US20090156569 Oral contraceptive spray |
| 06/18/2009 | US20090156568 Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods |
| 06/18/2009 | US20090156567 Novel anti-inflammatory androstane derivative |
| 06/18/2009 | US20090156566 Method of treating middle ear infections |
| 06/18/2009 | US20090156565 Composition and use thereof in enhancing a therapeutic effect of an antiepileptic drug |
| 06/18/2009 | US20090156564 Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels |
| 06/18/2009 | US20090156563 Glucan Compositions |
| 06/18/2009 | US20090156562 Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts |
| 06/18/2009 | US20090156561 Use of Cholinesterase Inhibitors In Smoking Cessation |
| 06/18/2009 | US20090156560 Tissue non-specific alkaline phosphatase inhibitors and uses thereof for treating vascular calcification |
| 06/18/2009 | US20090156559 2-{[2-(Diethylamino)ethyl]sulfonyl}ethyl N,N-bis(2-chloroethyl)phosphorodiamidate; chemical intermediates; free of by-products acrolein; release "cyclophosphate mustards" and do not require metabolic activation; anticarcinogenic agents; antitumor agents; autoimmune diseases |
| 06/18/2009 | US20090156558 Phosphonate analogs of antimetabolites |
| 06/18/2009 | US20090156557 Kinase inhibitors |
| 06/18/2009 | US20090156556 Aminopropanol derivatives |
| 06/18/2009 | US20090156555 Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors |
| 06/18/2009 | US20090156554 N-[1-(3-dimethylamino-4-formyl-phenyl)-3-pyridin-3-yl-4,5-dihydro-1H-pyrazolo[4,3-g]benzothiazol-7-yl]-acetamide; phosphatidylinositol-3-kinases (PI3-kinases) inhibitor; cell growth, differentiation and intracellular transport processes; antiproliferative, antiinflammatory agent; autoimmune diseases |
| 06/18/2009 | US20090156552 Topical delivery of phthalocyanines |
| 06/18/2009 | US20090156551 Novel composition |
| 06/18/2009 | US20090156550 Composition containing oligosaccharides for the treatment/prevention of infections |
| 06/18/2009 | US20090156549 Mucosal treatment |
| 06/18/2009 | US20090156548 Fluorocytidine derivatives and cox-2 inhibitors for the treatment of cancer |
| 06/18/2009 | US20090156547 1-(2,2-Difluoro-2-deoxy-b-D-ribofuranosyl)-4-(2-propyl-1-oxopentyl)amino-pyrimidin-2-one p-toluenesulfonic acid co-crystal; delivery by mouth;bioavailability; nontoxic; side effect reduction; hydrolysis to gemcitabinewith reduction of the formation of deoxydifluorouridine |
| 06/18/2009 | US20090156546 Compositions and methods for modulating the immune system |
| 06/18/2009 | US20090156545 Substituted Phosphate Esters of Nucleoside Phosphonates |
| 06/18/2009 | US20090156544 A1 adenosine receptor agonists |
| 06/18/2009 | US20090156543 Methods and compositions relating to expression factors |
| 06/18/2009 | US20090156542 MCP-1 Binding Nucleic Acids And Use Thereof |
| 06/18/2009 | US20090156541 for interfering with the DNA repair of double strand breaks (DSB); novel double-stranded nucleic acid molecules that act as baits and hijack the holocomplex of enzymes responsible of DNA DSB sensing, signaling and/or repair pathways |
| 06/18/2009 | US20090156540 Method for diagnosing and/or predicting the development of an allergic disorder and agents for treating and/or preventing same |
| 06/18/2009 | US20090156539 Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field |
| 06/18/2009 | US20090156538 Modulation of endothelial lipase expression |
| 06/18/2009 | US20090156537 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 06/18/2009 | US20090156536 AIMP2-DX2 Gene and SiRNA Targeting AIMP2-DX2 |
| 06/18/2009 | US20090156535 MicroRNAs for Modulating Herpes Virus Gene Expression |
| 06/18/2009 | US20090156534 Globin lentiviral vectors for treatment of disease |
| 06/18/2009 | US20090156533 chemically modified nucleic acid molecule; cancer; carcinoma, neovascularization, diabetic retinopathy, neovascular glaucoma, myopic degeneration and other proliferative diseases, restenosis and polycystic kidney disease |
| 06/18/2009 | US20090156532 SNP BINDING SITE FOR microRNAs IN HLA-G |
| 06/18/2009 | US20090156531 Use of Inhibitors of Scinderin and/or Ephrin-A1 for Treating Tumors |
| 06/18/2009 | US20090156530 Norepinepherine Transporter Mutants and Uses Thereof |
| 06/18/2009 | US20090156529 RNAi Inhibition of Alpha-ENaC Expression |
| 06/18/2009 | US20090156528 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/18/2009 | US20090156527 Antiviral oligonucleotides targeting viral families |
| 06/18/2009 | US20090156526 Compositions and methods for modulation of lmna expression |
| 06/18/2009 | US20090156525 Low-Density Lipoprotein Receptor-Related Protein 2 Clears Amyloid-Beta Peptide A cross the Blood-Brain Barrier via Apolipoprotein J |
| 06/18/2009 | US20090156524 Novel siRNAS and methods of use thereof |
| 06/18/2009 | US20090156523 Methods and compositions for modulating foxo1 activity and insulin signaling |
| 06/18/2009 | US20090156522 Pancreatic Cancer Genes |
| 06/18/2009 | US20090156521 Gpr17 modulators,method of screening and uses thereof |
| 06/18/2009 | US20090156520 Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA |
| 06/18/2009 | US20090156518 Stable pharmaceutical composition comprising beta-lactam antibiotic and buffer |
| 06/18/2009 | US20090156517 Stable pharmaceutical compositions of aminoglycoside antibiotics, ion-chelating agents, and buffers |
| 06/18/2009 | US20090156516 Benzylphenyl cyclohexane derivatives and methods of use |
| 06/18/2009 | US20090156515 Composition comprising triterpene saponins and compounds with angeloyl functional group, methods for preparing same and uses thereof |
| 06/18/2009 | US20090156514 Novel macrolactam compounds |
| 06/18/2009 | US20090156513 freeze-dried fruit pulp powder; antioxidants comprises a high concentration of anthocyanin; treating disease or injury and damage induced by pathological free radicals; has a cyclooxygenase inhibition value greater than Aspirin; anticarcinogenic, antiinflammatory, antiarthritic agents; aging resistance |
| 06/18/2009 | US20090156512 potent activity against resistant pneumococci |
| 06/18/2009 | US20090156511 Agent for Enhancing Antiseptic Power |
| 06/18/2009 | US20090156501 Identification of ligands by selective amplification of cells transfected with receptors |
| 06/18/2009 | US20090156476 Dimeric or Multimeric Microproteins |
| 06/18/2009 | US20090156474 Methods for treating obesity and obesity related diseases and disorders |
| 06/18/2009 | US20090156473 Pharmaceutical composition for the treatment of viral infections and/or tumor diseases by inhibiting protein folding and protein breakdown |
| 06/18/2009 | US20090156471 Use of anti-amyloid agents for treating and typing pathogen infections |
| 06/18/2009 | US20090156469 Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating waldenstrom's macroglobulinemia |
| 06/18/2009 | US20090156467 Thymic stromal lymphpoietin promoter and use therefor |
| 06/18/2009 | US20090156465 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |